These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7362666)

  • 41. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis.
    DeSilva RN; Eastmond CJ
    Clin Rheumatol; 1992 Jun; 11(2):216-9. PubMed ID: 1617896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis.
    Halverson PB; Kozin F; Bernhard GC; Goldman AL
    JAMA; 1978 Oct; 240(17):1870-2. PubMed ID: 691197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of continuing penicillamine and gold treatment on the course of penicillamine and gold nephropathy.
    Hall CL; Tighe R
    Br J Rheumatol; 1989 Feb; 28(1):53-7. PubMed ID: 2917229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
    Waskönig FW; Meyer W
    Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
    [No Abstract]   [Full Text] [Related]  

  • 51. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. General practitioner assistance with gold and penicillamine therapy of rheumatoid arthritis--a four year prospective study.
    Hunter JA; Capell HA; Pullar T; Madhok R
    Scott Med J; 1987 Jun; 32(3):74-6. PubMed ID: 3629220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract]   [Full Text] [Related]  

  • 54. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.
    Thomas D; Gallus AS; Brooks PM; Tampi R; Geddes R; Hill W
    Ann Rheum Dis; 1984 Jun; 43(3):402-6. PubMed ID: 6742902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 58. [Evans' syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination].
    Masson C; Brégeon C; Ifrah N; Berton V; Housseau F; Rénier JC
    Rev Rhum Mal Osteoartic; 1991; 58(7):519-22. PubMed ID: 1925397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absence of toxic or therapeutic interaction between penicillamine and previously administered gold in a trial of penicillamine in rheumatoid disease.
    Postgrad Med J; 1974 Aug; 50 Suppl 2():77-8. PubMed ID: 4619474
    [No Abstract]   [Full Text] [Related]  

  • 60. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.